{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:41:05Z","timestamp":1792453265427,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010127","name":"J\u00fcrgen Manchot Stiftung","doi-asserted-by":"publisher","award":["MOI-5 graduate school"],"award-info":[{"award-number":["MOI-5 graduate school"]}],"id":[{"id":"10.13039\/100010127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["JA 1479\/14-1"],"award-info":[{"award-number":["JA 1479\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      A considerable proportion of suspected pulmonary tuberculosis (pTB) cases are identified and treated on the basis of clinical diagnoses, as it is often not possible to confirm\n                      <jats:italic>Mycobacterium tuberculosis (Mtb)<\/jats:italic>\n                      infection. In the absence of pathogen detection, supplementary indicators, such as immunological biomarkers, would facilitate TB diagnostic decision-making.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this prospective case-control study conducted in Ghana, patients with suspected pTB (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200983) were divided into three subgroups: confirmed cases with high (pTB\n                      <jats:sub>high<\/jats:sub>\n                      ) or low (pTB\n                      <jats:sub>low<\/jats:sub>\n                      )\n                      <jats:italic>Mtb<\/jats:italic>\n                      sputum load, and clinically diagnosed patients without\n                      <jats:italic>Mtb<\/jats:italic>\n                      confirmation (pTB\n                      <jats:sub>clin<\/jats:sub>\n                      ). pTB patient subgroups were then compared with healthy contacts (controls;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200949) for their immune responses to\n                      <jats:italic>Mtb<\/jats:italic>\n                      antigens (i.e. PPD\n                      <jats:sub>\n                        <jats:italic>Mtb<\/jats:italic>\n                      <\/jats:sub>\n                      , ESAT6\/CFP10), the mitogen phytohemagglutinin, and a superantigen.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      About half of the pTB patients were pTB\n                      <jats:sub>clin<\/jats:sub>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200941; 49.4%), while pTB\n                      <jats:sub>high<\/jats:sub>\n                      accounted for only about one-third (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926; 31.3%) and pTB\n                      <jats:sub>low<\/jats:sub>\n                      for about one-fifth (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916; 19.3%). Antigen-specific CD4\n                      <jats:sup>+<\/jats:sup>\n                      T-cell responses varied among the pTB subgroups, and only the pTB\n                      <jats:sub>high<\/jats:sub>\n                      group had higher IFN\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      \/TNF\u03b1\n                      <jats:sup>+<\/jats:sup>\n                      T-cell proportions as compared to controls (PPD\n                      <jats:sub>Mtb<\/jats:sub>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0003; ESAT6\/CFP10,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). In contrast, phytohemagglutinin induced significantly lower proportions of CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells in all TB subgroups (pTB\n                      <jats:sub>high<\/jats:sub>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001; pTB\n                      <jats:sub>low<\/jats:sub>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0039; pTB\n                      <jats:sub>clin<\/jats:sub>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0012 for IFN\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      \/TNF\u03b1\n                      <jats:sup>+<\/jats:sup>\n                      ) and this measurement distinguished patient subgroups effectively from controls (pTB\n                      <jats:sub>high<\/jats:sub>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001; pTB\n                      <jats:sub>low<\/jats:sub>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0132; pTB\n                      <jats:sub>clin<\/jats:sub>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0006 for TNF\u03b1\n                      <jats:sup>+<\/jats:sup>\n                      \/CD40L\n                      <jats:sup>+<\/jats:sup>\n                      ). Finally, TNF\u03b1\n                      <jats:sup>+<\/jats:sup>\n                      \/CD40L\n                      <jats:sup>+<\/jats:sup>\n                      T-cell responses to phytohemagglutinine had the highest efficiency to distinguish pTB\n                      <jats:sub>clin<\/jats:sub>\n                      with severe lung manifestation from controls (AUC\u2009=\u20090.9;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001; 95%CI:0.82\u20130.98).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study underscores the importance of clinical pTB diagnosis and identifies a reduced T-cell cytokine response to phytohemagglutinin as a potential biomarker.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-026-03021-4","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:26:52Z","timestamp":1792405612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An impaired T-cell-mediated mitogen response as a potential biomarker to aid in clinical diagnosis of pulmonary tuberculosis"],"prefix":"10.1007","author":[{"given":"Difery","family":"Minadzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millicent","family":"Lamptey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika M.","family":"Vivekanandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert S.","family":"Ahor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred","family":"Aniagyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Sakyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A. A.","family":"Awuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejoice A.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria A.","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Kegya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Amoakoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Adankwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas O.","family":"Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma C.","family":"Anyitey-Kokor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed K.","family":"Abass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick G.","family":"Apraku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana K.","family":"Ayisi-Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Adane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salisu","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertan","family":"Mayatepek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Seyfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard O.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4703-5652","authenticated-orcid":false,"given":"Marc","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"issue":"9387","key":"3021_CR1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0140-6736(03)14333-4","volume":"362","author":"TR Frieden","year":"2003","unstructured":"Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C, Tuberculosis. Lancet. 2003;362(9387):887\u201399. https:\/\/doi.org\/10.1016\/S0140-6736(03)14333-4.","journal-title":"Lancet"},{"key":"3021_CR2","unstructured":"Organization WH. Global tuberculosis report. (2025). Accessed."},{"issue":"1","key":"3021_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12879-019-3716-x","volume":"19","author":"D Assefa","year":"2019","unstructured":"Assefa D, Belachew F, Wondimagegn G, Klinkenberg E. Missed pulmonary tuberculosis: a cross sectional study in the general medical inpatient wards of a large referral hospital in Ethiopia. BMC Infect Dis. 2019;19(1):60. https:\/\/doi.org\/10.1186\/s12879-019-3716-x.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"3021_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/00004836-198810000-00012","volume":"10","author":"MS Meiselman","year":"1988","unstructured":"Meiselman MS, Agha FP. Fistula to the pancreatic duct from a peptic ulcer. Case report and literature review. J Clin Gastroenterol. 1988;10(5):537\u201340. https:\/\/doi.org\/10.1097\/00004836-198810000-00012.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"3021_CR5","doi-asserted-by":"publisher","first-page":"ofv171","DOI":"10.1093\/ofid\/ofv171","volume":"2","author":"AC Miller","year":"2015","unstructured":"Miller AC, Polgreen LA, Cavanaugh JE, Hornick DB, Polgreen PM. Missed opportunities to diagnose tuberculosis are common among hospitalized patients and patients seen in emergency departments. Open Forum Infect Dis. 2015;2(4):ofv171. https:\/\/doi.org\/10.1093\/ofid\/ofv171.","journal-title":"Open Forum Infect Dis"},{"key":"3021_CR6","doi-asserted-by":"publisher","first-page":"721013","DOI":"10.3389\/fimmu.2021.721013","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, Xue Y, Mao L, Lin Q, Tang G, Song H, et al. Activation phenotype of Mycobacterium tuberculosis-specific CD4(+) T cells promoting the discrimination between active tuberculosis and latent tuberculosis infection. Front Immunol. 2021;12:721013. https:\/\/doi.org\/10.3389\/fimmu.2021.721013.","journal-title":"Front Immunol"},{"issue":"5","key":"3021_CR7","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1172\/JCI77990","volume":"125","author":"T Adekambi","year":"2015","unstructured":"Adekambi T, Ibegbu CC, Cagle S, Kalokhe AS, Wang YF, Hu Y, et al. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest. 2015;125(5):1827\u201338. https:\/\/doi.org\/10.1172\/JCI77990.","journal-title":"J Clin Invest"},{"issue":"1","key":"3021_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1365-2249.2002.01809.x","volume":"128","author":"DS Rodrigues","year":"2002","unstructured":"Rodrigues DS, Medeiros EA, Weckx LY, Bonnez W, Salomao R, Kallas EG. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Clin Exp Immunol. 2002;128(1):149\u201354. https:\/\/doi.org\/10.1046\/j.1365-2249.2002.01809.x.","journal-title":"Clin Exp Immunol"},{"key":"3021_CR9","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3389\/fimmu.2018.02247","volume":"9","author":"MIM Ahmed","year":"2018","unstructured":"Ahmed MIM, Ntinginya NE, Kibiki G, Mtafya BA, Semvua H, Mpagama S, et al. Phenotypic changes on Mycobacterium tuberculosis-specific CD4 T cells as surrogate markers for tuberculosis treatment efficacy. Front Immunol. 2018;9:2247. https:\/\/doi.org\/10.3389\/fimmu.2018.02247.","journal-title":"Front Immunol"},{"issue":"10","key":"3021_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1473-3099(14)70884-9","volume":"14","author":"D Portevin","year":"2014","unstructured":"Portevin D, Moukambi F, Clowes P, Bauer A, Chachage M, Ntinginya NE, et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis. 2014;14(10):931\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(14)70884-9.","journal-title":"Lancet Infect Dis"},{"key":"3021_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13761","author":"HS Ahor","year":"2024","unstructured":"Ahor HS, Vivekanandan M, Harelimana JD, Owusu DO, Adankwah E, Seyfarth J, et al. Immunopathology in human pulmonary tuberculosis: inflammatory changes in the plasma milieu and impaired host immune cell functions. Immunology. 2024. https:\/\/doi.org\/10.1111\/imm.13761.","journal-title":"Immunology"},{"key":"3021_CR12","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3389\/fimmu.2019.01518","volume":"10","author":"E Adankwah","year":"2019","unstructured":"Adankwah E, Lundtoft C, Guler A, Franken K, Ottenhoff THM, Mayatepek E, et al. Two-hit in vitro T-cell stimulation detects Mycobacterium tuberculosis infection in QuantiFERON negative tuberculosis patients and healthy contacts from Ghana. Front Immunol. 2019;10:1518. https:\/\/doi.org\/10.3389\/fimmu.2019.01518.","journal-title":"Front Immunol"},{"key":"3021_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2017.03.025","volume":"59","author":"MJ Bosco","year":"2017","unstructured":"Bosco MJ, Hou H, Mao L, Wu X, Ramroop KD, Lu Y, et al. The performance of the TBAg\/PHA ratio in the diagnosis of active TB disease in immunocompromised patients. Int J Infect Dis. 2017;59:55\u201360. https:\/\/doi.org\/10.1016\/j.ijid.2017.03.025.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"3021_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s15010-023-01977-1","volume":"51","author":"MM Vivekanandan","year":"2023","unstructured":"Vivekanandan MM, Adankwah E, Aniagyei W, Acheampong I, Minadzi D, Yeboah A, et al. Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment. Infection. 2023;51(4):1013\u201323. https:\/\/doi.org\/10.1007\/s15010-023-01977-1.","journal-title":"Infection"},{"issue":"4","key":"3021_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.5588\/ijtld.15.0756","volume":"20","author":"F Wang","year":"2016","unstructured":"Wang F, Hou HY, Wu SJ, Zhu Q, Huang M, Yin B, et al. Using the TBAg\/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area. Int J Tuberc Lung Dis. 2016;20(4):487\u201393. https:\/\/doi.org\/10.5588\/ijtld.15.0756.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3021_CR16","doi-asserted-by":"publisher","first-page":"641378","DOI":"10.3389\/fimmu.2021.641378","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, Xue Y, Cai Y, Lin Q, Tang G, Song H, et al. Lymphocyte non-specific function detection facilitating the stratification of Mycobacterium tuberculosis infection. Front Immunol. 2021;12:641378. https:\/\/doi.org\/10.3389\/fimmu.2021.641378.","journal-title":"Front Immunol"},{"issue":"3","key":"3021_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/imm.70131","volume":"178","author":"JF Arthur","year":"2026","unstructured":"Arthur JF, Ahor HS, Vivekanandan MM, Minadzi D, Yeboah A, Lamptey M, et al. Blood immunopathology of tuberculosis patients disrupts monocyte-dependent T-cell activation and cytokine expression. Immunology. 2026;178(3):494\u2013505. https:\/\/doi.org\/10.1111\/imm.70131.","journal-title":"Immunology"},{"issue":"2","key":"3021_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jinf.2020.11.032","volume":"82","author":"E Adankwah","year":"2021","unstructured":"Adankwah E, Nausch N, Minadzi D, Abass MK, Franken K, Ottenhoff THM, et al. Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis. J Infect. 2021;82(2):245\u201352. https:\/\/doi.org\/10.1016\/j.jinf.2020.11.032.","journal-title":"J Infect"},{"issue":"3","key":"3021_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00430-017-0501-6","volume":"206","author":"C Lundtoft","year":"2017","unstructured":"Lundtoft C, Awuah AA, Nausch N, Enimil A, Mayatepek E, Owusu-Dabo E, et al. Alternative quantiferon cytokines for diagnosis of children with active tuberculosis and HIV co-infection in Ghana. Med Microbiol Immunol. 2017;206(3):259\u201365. https:\/\/doi.org\/10.1007\/s00430-017-0501-6.","journal-title":"Med Microbiol Immunol"},{"key":"3021_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-026-04777-3","author":"A Arthur","year":"2026","unstructured":"Arthur A, Owusu DO, Minadzi D, Appau MN, Arthur B, Amoakoa LA, et al. Bacterial aetiology in the lower respiratory tract of TB-negative patients with respiratory symptoms: implications for tuberculosis control in Ghana. BMC Microbiol. 2026. https:\/\/doi.org\/10.1186\/s12866-026-04777-3.","journal-title":"BMC Microbiol"},{"issue":"1","key":"3021_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","volume":"18","author":"SE Dorman","year":"2018","unstructured":"Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, et al. Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76\u201384. https:\/\/doi.org\/10.1016\/S1473-3099(17)30691-6.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3021_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10096-023-04741-3","volume":"43","author":"I Acheampong","year":"2024","unstructured":"Acheampong I, Minadzi D, Laing EF, Frimpong M, Vivekanandan MM, Yeboah A, et al. Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients. Eur J Clin Microbiol Infect Dis. 2024;43(3):611\u20136. https:\/\/doi.org\/10.1007\/s10096-023-04741-3.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3021_CR23","unstructured":"Team RC. R: a language and environment for statistical computing. https:\/\/www.R-project.org\/ (2024). Accessed."},{"issue":"1","key":"3021_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1172\/jci110231","volume":"68","author":"ME Kleinhenz","year":"1981","unstructured":"Kleinhenz ME, Ellner JJ, Spagnuolo PJ, Daniel TM. Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility. J Clin Invest. 1981;68(1):153\u201362. https:\/\/doi.org\/10.1172\/jci110231.","journal-title":"J Clin Invest"},{"issue":"4","key":"3021_CR25","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1186\/cc13980","volume":"18","author":"JA Muszynski","year":"2014","unstructured":"Muszynski JA, Nofziger R, Greathouse K, Steele L, Hanson-Huber L, Nateri J, et al. Early adaptive immune suppression in children with septic shock: a prospective observational study. Crit Care. 2014;18(4):R145. https:\/\/doi.org\/10.1186\/cc13980.","journal-title":"Crit Care"},{"issue":"3","key":"3021_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00011-022-01543-9","volume":"71","author":"S Zivancevic-Simonovic","year":"2022","unstructured":"Zivancevic-Simonovic S, Jovanovic D, Cupurdija V, Milosevic-Djordjevic O, Stanojevic M, Marinkovic M, et al. Cytokine producing ability of peripheral blood cells from COVID-19 patients after unspecific in vitro stimulation. Inflamm Res. 2022;71(3):331\u201341. https:\/\/doi.org\/10.1007\/s00011-022-01543-9.","journal-title":"Inflamm Res"},{"key":"3021_CR27","first-page":"199","volume":"6","author":"J Clot","year":"1975","unstructured":"Clot J, Mathieu O, Sany J, Serre H. Mitogens of B and T cells from peripheral blood in rheumatoid arthritis. Rheumatology. 1975;6:199\u2013208.","journal-title":"Rheumatology"},{"key":"3021_CR28","first-page":"190","volume":"6","author":"AJ Rawson","year":"1975","unstructured":"Rawson AJ. Abnormalities of peripheral blood lymphocytes in rheumatoid arthritis. Rheumatology. 1975;6:190\u20138.","journal-title":"Rheumatology"},{"issue":"9","key":"3021_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1365-3083.1976.tb03057.x","volume":"5","author":"TG Abrahamsen","year":"1976","unstructured":"Abrahamsen TG, Froland SS, Natvig JB, Pahle J. Antigen and unspecific mitogen stimulation of lymphocytes eluted from rheumatoid inflammatory tissue. Scand J Immunol. 1976;5(9):1057\u201363. https:\/\/doi.org\/10.1111\/j.1365-3083.1976.tb03057.x.","journal-title":"Scand J Immunol"},{"issue":"3","key":"3021_CR30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/art.1780190301","volume":"19","author":"HA Silverman","year":"1976","unstructured":"Silverman HA, Johnson JS, Vaughan JH, McGlamory JC. Altered lymphocyte reactivity in rheumatoid arthritis. Arthritis Rheum. 1976;19(3):509\u201315. https:\/\/doi.org\/10.1002\/art.1780190301.","journal-title":"Arthritis Rheum"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-03021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-03021-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-03021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:04:43Z","timestamp":1792451083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-03021-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":30,"alternative-id":["3021"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-03021-4","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"5 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}